TABLE 3.
Gene | OMIM | Syndrome | References | Described regulator of: | References |
ATXN3 | 109150 | MACHADO-JOSEPH DISEASE | Kawaguchi et al. (1994) | Antiviral immunity | Feng et al. (2018) |
OTUD5 | 301056 | MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED | Beck et al. (2021); Tripolszki et al. (2021) | Antiviral immunity | Guo et al. (2020a) |
OTUD6B | 617452 | INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES | Santiago-Sim et al. (2017) | B-lymphocyte proliferation | Xu et al. (2011) |
OTUD7A | 612001 | CHROMOSOME 15q13.3 DELETION SYNDROME | Hoppman-Chaney et al. (2013) | DNA repair | Wu et al. (2019) |
STAMBP | 614261 | MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME | Hori et al. (2018) | Inflammasome | Bednash et al. (2017, 2021) |
UCHL1 | 615491, 613643 | SPASTIC PARAPLEGIA 79, PARKINSON DISEASE 5, AUTOSOMAL DOMINANT | Leroy et al. (1998) | TLR signaling | Karim et al. (2013) |
USP7 | 616863 | HAO-FOUNTAIN SYNDROME | Hao et al. (2015) | TLR signaling, antiviral immunity, NF-κB signalling, T-cell differentiation, Inflammasome | Daubeuf et al. (2009); Colleran et al. (2013); van Loosdregt et al. (2013); Cai et al. (2018); Palazon-Riquelme et al. (2018) |
USP9X | 300919; 300968 | MENTAL RETARDATION, X-LINKED 99; MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED | Homan et al. (2014) | T-cell signaling; TLR signaling | Naik et al. (2014); Naik and Dixit (2016); Xiang et al. (2019) |
USP18 | 617397 | PSEUDO-TORCH SYNDROME 2 | Meuwissen et al. (2016) | Antiviral immunity | Ritchie et al. (2004) |
USP27X | 300984 | MENTAL RETARDATION, X-LINKED 105 | Hu et al. (2016) | Antiviral immunity | Guo et al. (2019); Tao et al. (2020) |
The potential implication of the gene products in the regulation of innate and/or adaptive is indicated. When available, the OMIM (Online Mendelian Inheritance in Man®) disorder number is also reported.